Allogenic fetal mesenchymal stem cells from umbilical cord therapy(Fundacion Para La Investigacion Biomedica Del Hospital)

N/A

Report date: 2024/03/01 20:05:21

Base Information

Drug NameAllogenic fetal mesenchymal stem cells from umbilical cord therapy(Fundacion Para La Investigacion Biomedica Del Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Fetal-derivedCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsBronchopulmonary Dysplasia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesFundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal

China Registration ClassN/A

Develop Information

Active CompaniesFundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal

Inactive CompaniesN/A

Active IndicationsBronchopulmonary Dysplasia

Inactive IndicationsN/A

Other Information

ATC CodeN/A